Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74

This publication has 19 references indexed in Scilit:

• High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate
  Nuclear Medicine and Biology, 2001
• Delivery of the α-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules
  Nuclear Medicine and Biology, 2000
• Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies
  International Journal of Cancer, 1999
• Optimizations of Radiolabeling of Immunoproteins with ²¹³Bi
  Radiochimica Acta, 1997
• Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas
  Biochemical Journal, 1996
• The SCID Mouse Mutant: Definition, Characterization, and Potential Uses
  Annual Review of Immunology, 1991
• scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair.
  Proceedings of the National Academy of Sciences, 1991
• Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid mice
  International Journal of Cancer, 1990
• Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.
  Proceedings of the National Academy of Sciences, 1986
• Dose-Survival Curves of Human Cells in Tissue Culture Irradiated with Alpha-, Beta-, 20-KV. X- and 200-KV. X-Radiation
  Nature, 1962